跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 313 条关于
“Guangzhou Baiyunshan”
全部
313
临床试验
44
药物
135
机构
77
资讯
57
去年
Guangzhou Baiyunshan Receives Approval for Generic Drug
2个月前
Sanyou Bio and Baiyunshan Xihe Forge Strategic Alliance to Accelerate AI-Driven Radiopharmaceutical Development
去年
Global Review of Pyelonephritis Clinical Trials Reveals Key Trends and Top Companies
2年前
BioVersys Secures $6M Investment to Advance BV100 Clinical Program in China
去年
NKGen Biotech to Present Troculeucel Clinical Data for Alzheimer's Disease at Major International Conferences
去年
China Approves First-in-Class Influenza Drug Onradivir Targeting Novel PB2 Protein
去年
Innogen Seeks $100 Million Hong Kong IPO to Advance GLP-1 Pipeline
6个月前
Chinese Scientists Develop Revolutionary Mitochondrial Transplantation Therapy for Parkinson's Disease and Genetic Disorders
去年
New Global Report Reveals Comprehensive Landscape of Chemotherapy-Induced Diarrhea Clinical Trials
2个月前
Ivonescimab Outperforms Keytruda in Head-to-Head Phase III Trial, Signaling China's Biotech Ascent from the Greater Bay Area
第 1 页,共 6 页
上一页
下一页